Genetic Counseling

Personalized pre- and post-test counseling support

Get started

Non-invasive prenatal screening

Get started

Whole exome sequencing solution

Get started

Comprehensive carrier screening

Get started

Hereditary cancer panel testing

Get started

Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR)

Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is a reproductive genetic test where embryos generated by IVF are analyzed for the presence or absence of an unbalanced form of the rearrangement. Embryos that are normal or carriers of a balanced form of the rearrangement (like the carrier parent) are identified and transferred to the uterus during the same, or in a subsequent IVF cycle.

Who is PGT-SR for? 

PGT-SR is suitable for couples who are known to have a structural chromosome rearrangement and are therefore at risk of producing embryos with the incorrect chromosome complement. PGT-SR is indicated in the following cases:

  • Having a family history of an abnormal karyotype and balanced rearrangement (inversion, reciprocal translocation, or Robertsonian translocation) that has been confirmed in one of the partners
  • Couples who have had an affected child, or a previous pregnancy with an unbalanced chromosomal complement

Types of chromosome rearrangements tested for:

Why is PGT-SR recommended?

Individuals with structural chromosome rearrangements are usually healthy and only start encountering health issues when trying to conceive. The presence of these rearrangements can lead to the production of gametes (sperm or eggs) with the incorrect amount of genetic material. Such gametes will most likely not be viable enough to result in an embryo, which ultimately leads to infertility. However, some may survive but eventually result in the birth of a child with congenital abnormalities.

How is PGT-SR performed?

PGT-SR can identify embryos that are chromosomally normal and the ones which are carriers of a balanced form of rearrangement. Transferring only the healthy embryos into the uterus will ensure that the fetus will not be missing or have extra chromosomal material that will lead to the development of genetic disorders.

The report will detail the total number of embryos tested along with the chromosome complement of each. The report will also declare if any embryo carries a numerical chromosome abnormality, e.g., Down syndrome (extra copy of chromosome 21), or a segmental abnormality (due to the presence of an unbalanced form of the rearrangement).